Bortezomib and Prevacid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bortezomib (bortezomib) and Prevacid (lansoprazole). Common drug interactions include fall among females and spinal compression fracture among males.

The phase IV clinical study analyzes what interactions people have when they take Bortezomib and Prevacid. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Bortezomib?

Bortezomib has active ingredients of bortezomib. eHealthMe is studying from 30,912 Bortezomib users. Check the latest studies of Bortezomib.

What is Prevacid?

Prevacid has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 130,714 Prevacid users. Check the latest studies of Prevacid.

On Jul, 09, 2026

21 people who take Bortezomib and Prevacid together, and have interactions are studied.

Bortezomib and Prevacid drug interactions.

What are the common drug interactions of Bortezomib and Prevacid, by gender? *:

female:

Fall
Fatigue (feeling of tiredness)
Gastric ulcer haemorrhage (bleeding ulcer of stomach)
Oedema peripheral (superficial swelling)
Pain
Renal failure (kidney dysfunction)
Wrist fracture
Dizziness
Urinary tract infection
Alanine aminotransferase increased

male:

Spinal compression fracture (fracture due to spinal compression on bone)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Pleural effusion (water on the lungs)
Rash
Spinal column stenosis (narrowing of spinal column)
Spinal fracture (fracture in one of vertebrae)
Abdominal discomfort
Cerebral infarction (less blood supply to brain resulting tissue damage)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the common drug interactions of Bortezomib and Prevacid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood pressure increased
General physical health deterioration (weak health status)
Hypersensitivity
Infection
Plasma cell myeloma (cancer that begins in plasma cells)
Pulmonary alveolar haemorrhage (acute bleeding)
Red blood cell count decreased
Sinusitis (inflammation of sinus)

60+:

Fatigue (feeling of tiredness)
Dyspnoea (difficult or laboured respiration)
Back disorder
Death
Depression
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dizziness
Fracture
Intervertebral disc degeneration (spinal disc degeneration)
Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 19 people, 90.48%
Pain: 3 people, 14.29%
Nausea (feeling of having an urge to vomit): 3 people, 14.29%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Bortezomib and Prevacid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously